Introduction
in creating immunogenic neoepitopes and enhancing antigenic presentation of gliadins [5] .
Another inflammatory role of the tTG depends from its ability to mediate T-cell migration across cytokine-activated endothelium into inflamed tissues [6] . Thus, in the development of mucosal atrophy of CD, the tTG is overexpressed, particularly within the basement membrane and the lamina propria, with increased enterocyte expression compared to the controls displaying normal mucosa [7] .
The expression of tTG within specific areas suggests that the enzyme could be translocated from the intracellular to the pericellular environment in the lamina propria by some not yet identified cells. Moreover, the tTG deposits along the lamina propria and around the mucosal vessels represent a specific target of the IgA anti-tTG antibodies in revealing early developing CD among symptomatic and asymptomatic patients genetically predisposed to gluten intolerance [8, 9] . Furthermore, it has been recently reported that anti-tTG assay of the culture medium of biopsy specimens can improve the accuracy of CD diagnosis in patients negative for serum antibodies [10] .
Despite the interest in the biological properties of the tTG in the pathogenesis of CD, the distribution of this enzyme has been to date only studied by using one monoclonal antibody (CUB7402) developed against guinea-pig type tissue tTG enzyme and directed mainly against the loop-core region of the enzyme [11] [12] [13] .
The aim of the present study was to investigate the localization of tTG within the duodenal mucosa in controls and in different histological stages of CD and to identify the cells involved in the synthesis of tTG by using a new set of three anti-tTG monoclonal antibodies. These monoclonal antibodies were produced against recombinant human tTG and their epitopes were shown to be located in three distinct domains of the protein corresponding to the core, C1 and C2 protein structure [14] . 
Materials and methods

Study groups
Monoclonal antibody production and purification
Production and characterization of three different anti-tTG monoclonal antibodies was described elsewhere [14] . We identified the epitopes recognized by MAB 
Results
Localization of tTG within the mucosal duodenal sections with CUB4702
This antibody targets the Core-loop region of the tTG. In the first group of 18 CD patients, a strong staining was shown in epithelial cells and in the lamina propria of the villi under the superficial epithelium; the positivity was similar in frozen and fixed material (Fig. 1) . No significant differences in the localization of staining were observed with respect to the grade and severity of villous atrophy. In the control group (11 cases) , the distribution of the staining was the same as in CD patients (Fig. 2) .
Localization of tTG within the mucosal duodenal sections with the three new mAbs
The recently characterized mAbs directed to human tTG display all the determined epitopes corresponding to structural loops exposed on the surface of the protein [14] . These different recognition patterns account for the differences between the antibodies and, from a practical point of view, may be useful for experimental purposes. Thus, we analysed a second set of 30 CD cases with these three different mAbs. As it can be seen in Figure 3, (Fig. 5) . The staining observed for IgA was evident in plasma cells of the basal part of lamina propria (Fig. 6 ), but not in the lamina propria under the superficial epithelium. [17, 18] . The identification of tTG as the anti-endomysial autoantigen in this condition [19] allowed standardized tests to be introduced in clinical practice that proved tTG to be a reliable marker for CD [20, 21] . In fact, anti-tTG antibodies display high sensitivity (93%) and specificity (98%) for the diagnosis of CD, when villous atrophy is present [22] , and values 10 times higher than the cut-off are almost always associated with diagnostic pathological findings [23, 24] .
positivity was seen on epithelial cells, more evident for Mab 1 and Mab 3, and under the superficial epithelium in the axis of villi. As for the first set of samples positivity was similar for frozen and fixed material. Interestingly, mAb3 resulted also positive in Paneth cells (Fig. 4). Again, no discernible differences were observed with respect to the grade and severity of villous atrophy. A positive labelling (although of lesser intensity) was also observed in controls. CD31 and CD34 were positive in endothelial cells and vascular channels, with the same localization observed for tTG with CUB 7402 and the three Mabs
Discussion
To date, there are few doubts that tTG is an important component of CD, for both its pathogenesis and diagnosis
These antibodies are produced in the intestinal mucosa [25] and are deposited along the villous and crypt basement membranes in the mucosa from patients with CD before they can be detected in the circulation and before the mucosal damage is present [26] . Recent evidence in man also suggests that tTG autoantibodies per se may play an important role in the progression and maintenance of the trophic mucosal lesion in CD by interacting with extracellular membrane-bound tTG [27] . 3 (original magnification ϫ100) . We investigated whether the tTG expression by immunohistochemical methods might be useful in the evaluation of CD, since ultrastructural and enzymatic studies showed an increase of tTG in CD compared to controls [28] . To this purpose, we used the commercial mAb (CUB4702) and a new set of three mAbs recently characterized by our group. We decided to use multiple probes as in preliminary results we were able to show that these four monoclonal antibodies provide different staining patterns on histological sections of human umbilical cord. The most likely explanation of this finding is that tTG, the structure of which is highly sensitive to activation by Ca 2+ and GTP [29, 30] deamidation of gluten derived peptides by the Paneth's tTG enzyme leads to up-regulation of inflammatory immune response [32] .
Fig. 3 The arrows show the staining patterns of the three new mAbs in paraffin fixed sections. The figures above show initial lesions, the figures below show atrophic lesions. (A) and (D) mAb 1, (B) and (E) mAb 2, (C) and (F) mAb
It has been hypothesized that tTG crosslinks itself to gluten to make macromolecular complexes causing the formation of new antigens which are both self-epitopes and gliadin epitopes, leading to the production of anti-tTG antibodies [33, 34] . The anti-tTG antibodies are synthesized only at the intestinal site [25] , and the anti-tTG serum concentration is related to the degree of the intestinal lesion [35] . Furthermore, in the contest of genetically glutenintolerance and in the absence of morphological or serological signs of CD, patients show gluten-dependent anti-tTG intestinal deposits before the development of the villous atrophy [8, 9] [37] .
In conclusion, the assessment of tTG by immunohistochemical methods is not useful in the clinical diagnostic work-up of CD, whereas the detection of anti-tTG levels in patients' sera represents an important tool for both diagnostic and follow-up purposes [38, 39] .
